The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience

JAK-inhibitors are small molecules blocking the JAK-STAT pathway that have proven effective in the treatment of different immune-mediated diseases in adults and juvenile idiopathic arthritis (JIA). AIM OF STUDY: To evaluate the safety and efficacy of tofacitinib in children with different rheumatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostik, Mikhail M., Raupov, Rinat K., Suspitsin, Evgeny N., Isupova, Eugenia A., Gaidar, Ekaterina V., Gabrusskaya, Tatyana V., Kaneva, Maria A., Snegireva, Ludmila S., Likhacheva, Tatyana S., Miulkidzhan, Rimma S., Kosmin, Artem V., Tumakova, Anastasia V., Masalova, Vera V., Dubko, Margarita F., Kalashnikova, Olga V., Aksentijevich, Ivona, Chasnyk, Vyacheslav G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861449/
https://www.ncbi.nlm.nih.gov/pubmed/35211430
http://dx.doi.org/10.3389/fped.2022.820586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861449/
https://www.ncbi.nlm.nih.gov/pubmed/35211430
http://dx.doi.org/10.3389/fped.2022.820586

Ejemplares similares